Translations:Chronic kidney disease/16/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
Created page with "===Stages=== {| class=wikitable style="float:right; margin-left:5px" |- ! colspan = "7" | 慢性腎臓病 (CKD) ステージ - CKD G1-5 A1-3 <br />glomerular filtration rate/ja (GFR) と albumin/creatinine ratio/ja (ACR) |- ! colspan="4" rowspan="5" style="border: none; background: none;"|none|link=|20px |- ! colspan="3"| ACR |- | A1 || A2 || A3 |- | 正常~軽度増加 || 中程度の増加 || 著しく増加 |- | <30 || 30–300 || >300..."
 
No edit summary
 
Line 1: Line 1:
===Stages===
===ステージ===
{| class=wikitable style="float:right; margin-left:5px"
{| class=wikitable style="float:right; margin-left:5px"
|-
|-

Latest revision as of 23:56, 26 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Chronic kidney disease)
===Stages===
{| class=wikitable style="float:right; margin-left:5px"
|-
! colspan = "7" | Chronic kidney disease (CKD) staging - CKD G1-5 A1-3 <br />[[glomerular filtration rate]] (GFR) and [[albumin/creatinine ratio]] (ACR)
|-
! colspan="4" rowspan="5" style="border: none; background: none;"|[[File:Pfeil SO.svg|none|link=|20px]]
|-
! colspan="3"|  ACR
|-
| A1 || A2 || A3
|-
| Normal to mildly increased || Moderately increased || Severely increased
|-
| <30 || 30–300 || >300
|-
! rowspan = "7" | G <br /> F <br /> R
|-
| G1 || Normal || ≥ 90 || 1 if kidney damage present || 1 || 2
|-
| G2 || Mildly decreased || 60–89 || 1 if kidney damage present || 1 || 2
|-
| G3a || Mildly to moderately decreased || 45–59 || 1 || 2 || 3
|-
| G3b || Moderately to severely decreased || 30–44 || 2 || 3 || 3
|-
| G4 || Severely decreased || 15–29 || 3 || 4+ || 4+
|-
| G5 || Kidney failure || <15 || 4+ || 4+ || 4+
|-
| colspan = "7" |  Numbers 1–4 indicates risk of progression as well as frequency of monitoring (number of times a year). <br />  Kidney Disease Improving Global Outcomes - KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease 
|}

ステージ

慢性腎臓病 (CKD) ステージ - CKD G1-5 A1-3
glomerular filtration rate/ja (GFR) と albumin/creatinine ratio/ja (ACR)
ACR
A1 A2 A3
正常~軽度増加 中程度の増加 著しく増加
<30 30–300 >300
G
F
R
G1 正常 ≥ 90 腎臓に障害がある場合 1 1 2
G2 軽度減少 60–89 腎臓に障害がある場合 1 1 2
G3a 軽度から中等度の減少 45–59 1 2 3
G3b 中等度から重度の減少 30–44 2 3 3
G4 著しく減少 15–29 3 4+ 4+
G5 腎不全 <15 4+ 4+ 4+
1~4の数字は、進行のリスクとモニタリングの頻度(年何回)を示す。
腎臓病 世界的転帰の改善 - 慢性腎臓病の評価と管理に関するKDIGO 2012診療ガイドライン